William Blair & Company
ZBH icon

William Blair & Company’s Zimmer Biomet ZBH Stock Holding History

William Blair & Company’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Buy
19,251
+403
+2% +$37K 0.01% 773
2025
Q4 		$1.69M Sell
18,848
-4,223
-18% -$400K ﹤0.01% 785
2025
Q3 		$2.27M Sell
23,071
-760
-3% -$75.3K 0.01% 699
2025
Q2 		$2.17M Sell
23,831
-8,202
-26% -$793K 0.01% 697
2025
Q1 		$3.63M Buy
32,033
+70
+0.2% +$7.49K 0.01% 566
2024
Q4 		$3.38M Sell
31,963
-1,174
-4% -$126K 0.01% 593
2024
Q3 		$3.58M Sell
33,137
-898
-3% -$98K 0.01% 578
2024
Q2 		$3.69M Buy
34,035
+671
+2% +$79.1K 0.01% 546
2024
Q1 		$4.4M Buy
33,364
+1,184
+4% +$148K 0.01% 508
2023
Q4 		$3.92M Buy
32,180
+5,650
+21% +$630K 0.01% 519
2023
Q3 		$2.98M Buy
26,530
+2,982
+13% +$379K 0.01% 565
2023
Q2 		$3.43M Sell
23,548
-2,835
-11% -$385K 0.01% 526
2023
Q1 		$3.41M Sell
26,383
-308
-1% -$38.7K 0.01% 529
2022
Q4 		$3.4M Buy
26,691
+346
+1% +$40.2K 0.01% 512
2022
Q3 		$2.75M Buy
26,345
+295
+1% +$32.4K 0.01% 546
2022
Q2 		$2.74M Buy
26,050
+614
+2% +$72.8K 0.01% 558
2022
Q1 		$3.25M Sell
25,436
-1,003
-4% -$121K 0.01% 574
2021
Q4 		$3.26M Buy
26,439
+284
+1% +$37.2K 0.01% 595
2021
Q3 		$3.72M Buy
26,155
+3,719
+17% +$547K 0.01% 527
2021
Q2 		$3.5M Buy
22,436
+361
+2% +$58.5K 0.01% 545
2021
Q1 		$3.43M Sell
22,075
-662
-3% -$103K 0.01% 541
2020
Q4 		$3.4M Sell
22,737
-1,946
-8% -$275K 0.01% 520
2020
Q3 		$3.26M Buy
24,683
+1,427
+6% +$186K 0.01% 482
2020
Q2 		$2.69M Buy
23,256
+511
+2% +$58.9K 0.01% 497
2020
Q1 		$2.23M Sell
22,745
-6,364
-22% -$834K 0.01% 491
2019
Q4 		$4.23M Sell
29,109
-1,613
-5% -$223K 0.02% 427
2019
Q3 		$4.09M Buy
30,722
+5,567
+22% +$719K 0.02% 413
2019
Q2 		$2.88M Buy
25,155
+1,260
+5% +$148K 0.02% 484
2019
Q1 		$2.96M Sell
23,895
-239
-1% -$27.2K 0.02% 466
2018
Q4 		$2.43M Buy
24,134
+46
+0.2% +$5.17K 0.02% 486
2018
Q3 		$3.08M Buy
24,088
+70
+0.3% +$8.32K 0.02% 467
2018
Q2 		$2.6M Sell
24,018
-1,359
-5% -$148K 0.02% 497
2018
Q1 		$2.69M Sell
25,377
-3,444
-12% -$400K 0.02% 488
2017
Q4 		$3.38M Buy
28,821
+2,678
+10% +$303K 0.02% 445
2017
Q3 		$2.97M Buy
26,143
+909
+4% +$105K 0.02% 455
2017
Q2 		$3.15M Buy
25,234
+9,206
+57% +$1.09M 0.02% 456
2017
Q1 		$1.83M Buy
16,028
+132
+0.8% +$15K 0.01% 562
2016
Q4 		$1.59M Buy
15,896
+3,255
+26% +$349K 0.01% 548
2016
Q3 		$1.6M Sell
12,641
-265
-2% -$32.7K 0.01% 542
2016
Q2 		$1.51M Buy
12,906
+2,111
+20% +$239K 0.01% 523
2016
Q1 		$1.12M Sell
10,795
-1,177
-10% -$114K 0.01% 595
2015
Q4 		$1.19M Buy
11,972
+1,317
+12% +$129K 0.01% 585
2015
Q3 		$971K Sell
10,655
-1,662
-13% -$167K 0.01% 769
2015
Q2 		$1.3M Sell
12,317
-7,550
-38% -$835K ﹤0.01% 1501
2015
Q1 		$2.27M Buy
19,867
+205
+1% +$23.4K ﹤0.01% 1277
2014
Q4 		$2.17M Sell
19,662
-113
-0.6% -$11.9K ﹤0.01% 1258
2014
Q3 		$1.93M Buy
19,775
+9,035
+84% +$889K ﹤0.01% 1268
2014
Q2 		$1.08M Buy
10,740
+733
+7% +$71.5K ﹤0.01% 1431
2014
Q1 		$918K Buy
10,007
+120
+1% +$11.1K ﹤0.01% 1457
2013
Q4 		$894K Buy
9,887
+72
+0.7% +$6.23K ﹤0.01% 1415
2013
Q3 		$782K Sell
9,815
-1,157
-11% -$91.1K ﹤0.01% 1411
2013
Q2 		$798K Buy
+10,972
New +$820K ﹤0.01% 1354

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company's ZBH Position: Q1 2026 in Review

William Blair & Company increased its Zimmer Biomet (ZBH) stake by 2.1% in Q1 2026, buying an estimated $37K and bringing the position to 19,251 shares worth $1.74M. The position accounts for 0.01% of the portfolio, ranked #773.

William Blair & Company first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.4M in Q1 2024. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • William Blair & Company held 19,251 shares of Zimmer Biomet worth $1.74M as of Q1 2026.
  • William Blair & Company bought 403 Zimmer Biomet shares in Q1 2026, an estimated $37K.
  • Zimmer Biomet made up 0.01% of William Blair & Company's portfolio in Q1 2026, its #773 holding.
  • William Blair & Company first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's Zimmer Biomet position peaked at $4.4M in Q1 2024.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.